Late pregnancy β blocker exposure and risks of neonatal hypoglycemia and bradycardia

Pediatrics

Volumn 138, Issue 3, 2016, Pages

  Bateman, Brian T ^a,b   Patorno, Elisabetta ^a   Desai, Rishi J ^a   Seely, Ellen W ^a   Mogun, Helen ^a   Maeda, Ayumi ^b   Fischer, Michael A ^a   Hernandez Diaz, Sonia ^c   Huybrechts, Krista F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LABETALOL; METOPROLOL;

ADULT; AGE; ARTICLE; BRADYCARDIA; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DRUG INDICATION; FEMALE; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MATERNAL EXPOSURE; NEONATAL BRADYCARDIA; NEONATAL HYPOGLYCEMIA; NEWBORN; NEWBORN DISEASE; OBSTETRIC DELIVERY; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRIORITY JOURNAL; RISK; THIRD TRIMESTER PREGNANCY; YOUNG ADULT; CHEMICALLY INDUCED; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROPENSITY SCORE;

ADRENERGIC BETA-ANTAGONISTS; ATENOLOL; BRADYCARDIA; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; HYPOGLYCEMIA; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LABETALOL; MALE; MATERNAL EXPOSURE; METOPROLOL; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROPENSITY SCORE;

EID: 84985995798     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2016-0731     Document Type: Article

References (28)

1. Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol. 2009;113(6):1299-1306
2. ACOG Committee on Practice Bulletins - Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2002;99(1):159-167
3. Bateman BT, Bansil P, Hernandez-Diaz S, Mhyre JM, Callaghan WM, Kuklina EV. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012;206(2):134. e1-134.e8
4. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 125: Chronic hypertension in pregnancy. Obstet Gynecol. 2012;119(2 Pt 1):396-407
5. Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372(5):407-417
6. Tita AT, Sibai BM, Oparil S. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372(24):2366-2367
7. Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2014;(2):CD002252
8. Andrade SE, Raebel MA, Brown J, et al. Outpatient use of cardiovascular drugs during pregnancy. Pharmacoepidemiol Drug Saf. 2008;17(3):240-247
9. Bateman BT, Hernandez-Diaz S, Huybrechts KF, et al. Patterns of outpatient antihypertensive medication use during pregnancy in a Medicaid population. Hypertension. 2012;60(4):913-920
10. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122-1131
11. Davis RL, Eastman D, McPhillips H, et al. Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy. Pharmacoepidemiol Drug Saf. 2011;20(2):138-145
12. Daskas N, Crowne E, Shield JP. Is labetalol really a culprit in neonatal hypoglycaemia? Arch Dis Child Fetal Neonatal Ed. 2013;98(2):F185
13. Tam EW, Widjaja E, Blaser SI, Macgregor DL, Satodia P, Moore AM. Occipital lobe injury and cortical visual outcomes after neonatal hypoglycemia. Pediatrics. 2008;122(3):507-512
14. Burns CM, Rutherford MA, Boardman JP, Cowan FM. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics. 2008;122(1):65-74
15. Palmsten K, Huybrechts KF, Mogun H, et al. Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations. PLoS One. 2013;8(6):e67405
16. Margulis AV, Setoguchi S, Mittleman MA, Glynn RJ, Dormuth CR, Hernández-Díaz S. Algorithms to estimate the beginning of pregnancy in administrative databases. Pharmacoepidemiol Drug Saf. 2013;22(1):16-24
17. Palmsten K, Huybrechts KF, Michels KB, et al. Antidepressant use and risk for preeclampsia. Epidemiology. 2013;24(5):682-6910
18. Palmsten K, Hernández-Díaz S, Huybrechts KF, et al. Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ. 2013;347:f4877
19. Bateman BT, Hernandez-Diaz S, Huybrechts KF, et al Outpatient calcium-channel blockers and the risk of postpartum haemorrhage: a cohort study. BJOG. 2013;120(13):1668-1676; discussion 1676-1667
20. Desai RJ, Hernandez-Diaz S, Bateman BT, Huybrechts KF. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol. 2014;123(5):997-1002
21. Huybrechts KF, Palmsten K, Avorn J, et al. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med. 2014;370(25):2397-2407
22. Bateman BT, Hernandez-Diaz S, Fischer MA, et al. Statins and congenital malformations: cohort study. BMJ. 2015;350:h1035
23. Desai RJ, Huybrechts KF, Hernandez- Diaz S, et al. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ. 2015;350:h2102
24. Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009;20(4):512-522
25. Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2003; (3):CD002863
26. Boluyt N, van Kempen A, Offringa M. Neurodevelopment after neonatal hypoglycemia: a systematic review and design of an optimal future study. Pediatrics. 2006;117(6):2231-2243
27. Adamkin DH; Committee on Fetus and Newborn. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics. 2011;127(3):575-579
28. Schneeweiss S, Patrick AR, Stürmer T, et al. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care. 2007;45(10 Supl 2):S131-S142